トロンボフィリア:新しい要因は古い要因Vである.

An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.

Journal of thrombosis and haemostasis : JTH·2013

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.

Journal of thrombosis and haemostasis : JTH·2010

Optimizing warfarin reversal--an ex vivo study.

Journal of thrombosis and haemostasis : JTH·2009

450 million years of hemostasis.

Journal of thrombosis and haemostasis : JTH·2003

Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.

Xenotransplantation·2001

Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).

British journal of haematology·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Intra-arterial thrombolysis agents following endovascular thrombectomy for acute ischemic stroke: a network meta-analysis.

Frontiers in pharmacology·2026

Lidocaine Versus Amiodarone in Patients With Shockable Out-of-Hospital Cardiac Arrest: A Target Trial Emulation.

Critical care medicine·2026

Combined Left Atrial Appendage Closure and Pulmonary Vein Re-Isolation in Very-High Stroke-Risk Patients.

Pacing and clinical electrophysiology : PACE·2026

Intraoperative Ischemia Threshold and Outcomes of Emergency Vascular Repair During Orthopaedic Arthroplasty: A Time-Critical Analysis from a Dedicated On-Call Vascular Service.

Journal of clinical medicine·2026

Periarticular Embolization as an Alternative Treatment for Surgery-Ineligible Patients with Hip Osteoarthritis: A Prospective Comparative Study.

Journal of clinical medicine·2026

Spontaneous Coronary Artery Dissection, Apical Thrombus and Unknown Hyperthyroidism: A Clinical Case.

Journal of clinical medicine·2026

関連する実験動画

トロンボフィリア:新しい要因は古い要因Vである

関連する概念動画

An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.

Optimizing warfarin reversal--an ex vivo study.

450 million years of hemostasis.

Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.

Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Intra-arterial thrombolysis agents following endovascular thrombectomy for acute ischemic stroke: a network meta-analysis.

Lidocaine Versus Amiodarone in Patients With Shockable Out-of-Hospital Cardiac Arrest: A Target Trial Emulation.

Combined Left Atrial Appendage Closure and Pulmonary Vein Re-Isolation in Very-High Stroke-Risk Patients.

Intraoperative Ischemia Threshold and Outcomes of Emergency Vascular Repair During Orthopaedic Arthroplasty: A Time-Critical Analysis from a Dedicated On-Call Vascular Service.

Periarticular Embolization as an Alternative Treatment for Surgery-Ineligible Patients with Hip Osteoarthritis: A Prospective Comparative Study.

Spontaneous Coronary Artery Dissection, Apical Thrombus and Unknown Hyperthyroidism: A Clinical Case.

関連する実験動画

トロンボフィリア:新しい要因は古い要因Vである

関連する概念動画

関連記事